MedTrace Logo

Impact of a Pain Neuroscience Education Program on Primary Students with and Without Intellectual Disabilities

NCT06664606 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 413

Last updated 2024-11-08

No results posted yet for this study

Summary

This observational study evaluates the impact of a Pain Neuroscience Education (PNE) program on primary school students in Extremadura, Spain. The study examines satisfaction levels and knowledge acquisition regarding pain neuroscience among students with and without intellectual disabilities. Conducted across both rural and urban educational centers, as well as special and regular education schools, this study aims to identify the effectiveness of PNE in enhancing pain-related knowledge and addressing Sustainable Development Goals (SDGs) awareness. Additionally, the program includes interactive educational activities tailored for accessibility, using resources such as easy-to-read questionnaires and hands-on models, to support inclusive health education. Data collection involves pre- and post-intervention questionnaires to assess satisfaction and knowledge gains, with statistical analysis exploring differences between demographic and school-type groups.

Conditions

  • Chronic Pain (back / Neck)

Interventions

BEHAVIORAL

Pain Neuroscience Education Program (PNE)

The Pain Neuroscience Education (PNE) Program is a structured educational intervention aimed at primary school students with and without intellectual disabilities. This program introduces students to basic concepts of pain neuroscience, designed to increase understanding of pain mechanisms and promote healthy pain coping strategies. The intervention was adapted to 'easy reading' format to ensure accessibility for students with intellectual disabilities, and was delivered in both rural and urban school settings in Extremadura, Spain.

Sponsors & Collaborators

  • Universidad de Extremadura

    lead OTHER

Principal Investigators

  • Luis Espejo-Antúnez, Ph.D. · University of Extremadura

Eligibility

Min Age
10 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2024-05-31
Completion
2024-06-15

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06664606 on ClinicalTrials.gov